hPD-1

General Information

Strain Name

B6-Pdcd1em1(hPdcd1)/Vst

Common Name

hPD-1

Origin

Beijing Vitalstar Biotechnology Co., Ltd.

Background

C57BL/6NCrl

Coat Color

Black

Related gene

PD1


Development

PD-1 is an important immunosuppressive molecule and a member of the CD28 superfamily. Vitastar has developed PD-1 humanized mice, which, after inoculation with MC38 tumor cells and injection with the PD-1 inhibitor Keytruda, show significant tumor reduction and disappearance, and can be used for PD-1-related efficacy or drug screening experiments. Additionally, targeting PD-1 has significant implications for cancer immunotherapy, infection resistance, autoimmune disease resistance, and organ transplantation survival.

Using the CRISPR-Cas9 assisted method, the extracellular domain of the mouse programmed cell death 1 gene (Pdcd1 or PD-1, programmed death 1) was replaced with the human sequence. In this way, in the PD-1 humanized mice, the human PD-1 antibody inhibitor can be recognized and used for related efficacy or drug screening experiments.

image.png

Fig 1. hPD-1 mouse construction strategy

Phenotype

1. Splenic lymphocyte hPD-1 detection

11.png

Fig 2. hPD1 expression in splenic lymphocytes of hPD-1 mice detected by FACS

Application Cases

1. Constructing colon cancer model and evaluating therapeutic efficacy

111.png            112.png            113.png

Fig 3. hPD-1 mice transplanted with MC38 and Keytruda efficacy

hPD-1 mice were subcutaneously inoculated with mouse MC38, and when the tumors grew to about 100 mm3, the animals were randomly divided into 2 groups (n=6, 3 male and 3 female), the control group was injected with saline, and the experimental group was injected with Keytruda, and the drug was administered twice a week, and the drug was administered for 6 consecutive times. The results showed that Keytruda exhibited significant tumor-suppressive effects in hPD-1 mice; both female and male hPD-1 mice were ideal models for in vivo pharmacodynamic testing.

hPD-1 Mice Applications

1. PD-1 related efficacy or drug screening experiments

2. Research on PD-1-targeted immunomodulation for anti-tumor, anti-infection, anti-autoimmune diseases and organ transplantation survival

Reference

1. Shinohara T, Taniwaki M, Ishida Y, et al. Structure and chromosomal localization of the human PD-1 gene (PDCD1). Genomics. 1994, 23(3): 704–706.


Contact Us
contact
If you need assistance
please feel free to contact us at any time
animalmodel@vital-bj.com
+8610-84928167
© copyright维通达生物技术有限公司 京ICP备********号